Webby high-performance liquid chromatography (HPLC) applying the procedure described in the USP monograph for this agent using the Waters HPLC e2695 Separation Module (Waters, Milford, Massachusetts, USA).15 ... peritoneal dialysis: evaluation with CT peritoneography. Radiographics 1997; 17: 869–878. 31. Scanziani R, Pozzi M, Pisano L, … WebThe toxicity and pharmacokinetics of cis-diamminedichloroplatinum (cisplatin) (90 mg/sq m) administered as a single 4-hr peritoneal dialysis, with or without concurrent i.v. …
Pharmacokinetics of concomitant cisplatin and paclitaxel …
WebMar 1, 1987 · We administered cisplatin and etoposide by peritoneal dialysis to 39 patients with i.p. malignancies in order to investigate the toxicity, pharmacokinetics, and clinical activity of this 2-drug combination. All patients received i.v. sodium thiosulfate concurrently with the i.p. chemotherapy. WebCisplatin-induced kidney toxicity is reviewed here. The use of cisplatin in patients with pre-existing kidney dysfunction and the kidney effects of the platinum analogs, carboplatin and oxaliplatin, are discussed elsewhere. (See "Chemotherapy nephrotoxicity and dose modification in patients with kidney impairment: Conventional cytotoxic agents" .) dewslt cordless flashlight specs
Stability and compatibility of antibiotics in peritoneal dialysis ...
Webor dialysis care team should measure your remaining kidney function. This is measured by a blood test and 24-hour urine collection. It should be checked within the first month after starting dialysis and every four months thereafter, if your urine output is stable. However, if your urine output is decreasing, your remaining kidney function should WebFollow the recommended continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) connection procedures Steps before disconnecting: Use … WebOct 24, 2024 · • peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD), ... (HPLC), or at least 15 mg/L when measured by Fluorescence Polarization Immunoassay (FPIA) method. ... colistin, amphotericin B, ciclosporin, and cisplatin) should be carefully monitored, and should get auditory tests (see “Ototoxicity” below). ... church stationery